Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study

Autor: de Wit, R. Wuelfing, C. Castellano, D. Kramer, G. and Eymard, J. -C. Sternberg, C. N. Fizazi, K. Tombal, B. and Bamias, A. Carles, J. Iacovelli, R. Melichar, B. and Sverrisdottir, A. Theodore, C. Feyerabend, S. Helissey, C. and Foster, M. C. Ozatilgan, A. Geffriaud-Ricouard, C. de Bono, J.

Background: There is growing evidence that a high neutrophil-to-lymphocyte ratio (NLR) is associated with poor overall survival (OS) for patients with metastatic castration-resistant prostate cancer (mCRPC). In the CARD study (NCT02485691), cabazitax

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::3ed26e42fab2e7159cfe0ccd7dbe8d33
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3030868

Prognostic effect of systemic immune-inflammation index (SII) in 987 patients with advanced/metastatic urinary tract carcinoma (mUTC) treated with atezolizumab in the real-world global SAUL study

Autor: Mego, M., Huddart, R. A., Voortman, J., Ong, M., Gedye, C., Gurney, H., Fay, A. P., Bamias, A., Mellado Gonzalez, B., Loriot, Y., Merseburger, A. S., Castellano Gauna, D., de Ducla, S., Pavlova, J., Fear, S., Sternberg, C. N.

Publikováno v: Annals of Oncology, 31, S591-S591. Oxford University Press
Mego, M, Huddart, R A, Voortman, J, Ong, M, Gedye, C, Gurney, H, Fay, A P, Bamias, A, Mellado Gonzalez, B, Loriot, Y, Merseburger, A S, Castellano Gauna, D, de Ducla, S, Pavlova, J, Fear, S & Sternberg, C N 2020, ' Prognostic effect of systemic immune-inflammation index (SII) in 987 patients with advanced/metastatic urinary tract carcinoma (mUTC) treated with atezolizumab in the real-world global SAUL study ', Annals of Oncology, vol. 31, pp. S591-S591 . https://doi.org/10.1016/j.annonc.2020.08.838

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::24d6545c8ec7c5acc66ba6e2ec8909b4
https://research.vumc.nl/en/publications/87c55a6e-4faf-48ed-aea2-27cb08420fe9

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.